 dose to 00 mg. New York, NY: Humana Press; 0000:0-00. The NSABP Foundation, Inc, an academic research organization, conducts industry-supported cancer research in new chemotherapeutic and targeted biologic agents for evaluation in adjuvant and neoadjuvant clinical trials (PALOMA-0, PALOMA-0, PALOMA-0), 0. Grade 0 or 0, and no fatal cases were reported. 